Suchergebnisse - "Freedman, Jamie"

PubPharm (22)

1

A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access

enthalten in: Clinical pharmacology and therapeutics | 2023

von Mohan, S. | Freedman, J.

2

A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Mohan, S. | Freedman, J.

3

Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia

enthalten in: bioRxiv.org | 2022

von Salama, C. | Han, J. | Yau, L. | +17

4

Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop

enthalten in: JCO global oncology | 2022

von Kizub, D. | Manner, C. | Graef, K. | +14

ErratumIn: JCO Glob Oncol. 2022 Aug;8:e2200230. - PMID 35998114

5

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

enthalten in: The New England journal of medicine | 2021

von Salama, C. | Han, J. | Yau, L. | +17

CommentIn: N Engl J Med. 2021 Apr 15;384(15):1473. - PMID 33657286

6

Using patient-initiated study participation in the development of evidence for personalized cancer therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2011

von Ambrose, L. | Freedman, J. | Buetow, K. | +2

CommentIn: Clin Cancer Res. 2011 Nov 1;17(21):6632-3. - PMID 22046023

7

Using Patient-Initiated Study Participation in the Development of Evidence for Personalized Cancer Therapy

enthalten in: Clinical cancer research | 2011

von Ambrose, L. | Freedman, J. | Buetow, K. | +2

8

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

enthalten in: European journal of pharmacology | 2011

von Maher, M. | Bhattacharya, A. | Ao, H. | +18

9

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

enthalten in: European journal of pharmacology | 2011

von Maher, M. | Bhattacharya, A. | Ao, H. | +18

10

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide] : a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability

enthalten in: The Journal of pharmacology and experimental therapeutics | 2011

von Morton, M. | Barrett, T. | Freedman, J. | +14